$294 Million is the total value of Affinity Asset Advisors, LLC's 72 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 80.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $43,596,000 | +191.5% | 110,000 | +175.0% | 14.80% | +86.8% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $35,574,000 | +222.8% | 577,500 | +272.6% | 12.08% | +106.8% |
| ARKG | Buy | ARK ETF TRput | $21,295,000 | +470.9% | 240,000 | +500.0% | 7.23% | +265.8% |
| MORF | Buy | MORPHIC HLDG INC | $12,340,000 | +444.8% | 195,000 | +188.9% | 4.19% | +249.0% |
| CRIS | Sell | CURIS INC | $11,320,000 | -4.7% | 1,000,000 | -31.0% | 3.84% | -38.9% |
| VRTX | New | VERTEX PHARMACEUTICALS INCcall | $10,745,000 | – | 50,000 | +100.0% | 3.65% | – |
| VINC | Buy | VINCERX PHARMA INC | $10,480,000 | +24.4% | 543,010 | +34.7% | 3.56% | -20.3% |
| KURA | Buy | KURA ONCOLOGY INC | $10,319,000 | +21.5% | 365,000 | +40.4% | 3.50% | -22.2% |
| ARYA | Buy | ARYA SCIENCES ACQUISITION CO | $9,494,000 | +191.7% | 689,000 | +129.7% | 3.22% | +86.9% |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $7,331,000 | – | 700,000 | +100.0% | 2.49% | – |
| XLRN | ACCELERON PHARMA INC | $6,102,000 | +6.0% | 45,000 | 0.0% | 2.07% | -32.1% | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $5,601,000 | – | 222,267 | +100.0% | 1.90% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $5,493,000 | – | 220,000 | +100.0% | 1.86% | – |
| NARI | Buy | INARI MED INC | $5,350,000 | +512.8% | 50,000 | +400.0% | 1.82% | +292.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INCcall | $4,260,000 | +27.3% | 190,500 | +26.6% | 1.45% | -18.4% |
| RETROPHIN INCnote 2.500% 9/1 | $4,069,000 | +0.8% | 4,000,000 | 0.0% | 1.38% | -35.4% | ||
| LSAQ | Buy | LIFESCI ACQUISITION II CORP | $4,056,000 | +26.7% | 400,000 | +33.3% | 1.38% | -18.9% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $3,771,000 | -34.5% | 85,000 | -19.0% | 1.28% | -58.0% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $3,733,000 | -18.0% | 227,500 | +3.4% | 1.27% | -47.5% |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $3,707,000 | -17.2% | 270,000 | 0.0% | 1.26% | -46.9% | |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $3,564,000 | +419.5% | 300,000 | +200.0% | 1.21% | +232.4% |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $3,363,000 | – | 77,500 | +100.0% | 1.14% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $3,221,000 | -2.2% | 35,000 | -22.2% | 1.09% | -37.3% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $3,033,000 | +35.5% | 900,000 | +44.0% | 1.03% | -13.2% |
| MSACU | New | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $2,955,000 | – | 300,000 | +100.0% | 1.00% | – |
| CRIS | New | CURIS INCcall | $2,830,000 | – | 250,000 | +100.0% | 0.96% | – |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $2,720,000 | +14.3% | 175,000 | +16.7% | 0.92% | -26.7% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $2,702,000 | +194.3% | 380,000 | +223.3% | 0.92% | +88.5% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $2,678,000 | +103.8% | 130,000 | +73.3% | 0.91% | +30.6% |
| EPIX | New | ESSA PHARMA INC | $2,615,000 | – | 90,000 | +100.0% | 0.89% | – |
| ASND | New | ASCENDIS PHARMA A/Sput | $2,578,000 | – | 20,000 | +100.0% | 0.88% | – |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $2,578,000 | +54.6% | 20,000 | +100.0% | 0.88% | -1.0% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $2,569,000 | +200.5% | 100,000 | +122.2% | 0.87% | +92.5% |
| ZYME | Buy | ZYMEWORKS INC | $2,526,000 | -17.8% | 80,000 | +23.1% | 0.86% | -47.3% |
| HSAQ | Buy | HEALTH SCIENCES ACQ CORP 2 | $2,518,000 | -1.7% | 225,000 | +12.5% | 0.86% | -37.0% |
| LUNG | Buy | PULMONX CORP | $2,058,000 | +49.1% | 45,000 | +125.0% | 0.70% | -4.4% |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $1,986,000 | – | 27,000 | +100.0% | 0.67% | – |
| RUBY | New | RUBIUS THERAPEUTICS INCcall | $1,855,000 | – | 70,000 | +100.0% | 0.63% | – |
| STRO | Sell | SUTRO BIOPHARMA INC | $1,821,000 | -58.1% | 80,000 | -60.0% | 0.62% | -73.1% |
| CAPA | New | HIGHCAPE CAP ACQUISITION COR | $1,788,000 | – | 150,000 | +100.0% | 0.61% | – |
| BFLY | New | BUTTERFLY NETWORK INC | $1,683,000 | – | 100,000 | +100.0% | 0.57% | – |
| BLUE | New | BLUEBIRD BIO INCcall | $1,508,000 | – | 50,000 | +100.0% | 0.51% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,375,000 | +3.3% | 85,000 | +70.0% | 0.47% | -33.9% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $1,295,000 | – | 50,000 | +100.0% | 0.44% | – |
| BLU | New | BELLUS HEALTH INC NEW | $1,152,000 | – | 300,000 | +100.0% | 0.39% | – |
| IMVT | New | IMMUNOVANT INCcall | $1,123,000 | – | 70,000 | +100.0% | 0.38% | – |
| BCTG | BCTG ACQUISITION CORP | $1,112,000 | -2.8% | 100,000 | 0.0% | 0.38% | -37.6% | |
| GLPG | New | GALAPAGOS NVspon adr | $964,000 | – | 12,500 | +100.0% | 0.33% | – |
| CYTK | Sell | CYTOKINETICS INC | $930,000 | -36.1% | 40,000 | -42.9% | 0.32% | -59.0% |
| VINCW | Buy | VINCERX PHARMA INC*w exp 12/24/2025 | $881,000 | +40.5% | 218,000 | +14.7% | 0.30% | -9.9% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $815,000 | -62.4% | 20,000 | -60.0% | 0.28% | -75.9% |
| AFIB | New | ACUTUS MED INC | $802,000 | – | 60,000 | +100.0% | 0.27% | – |
| MGNX | New | MACROGENICS INC | $796,000 | – | 25,000 | +100.0% | 0.27% | – |
| CHAQU | New | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $789,000 | – | 75,000 | +100.0% | 0.27% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $779,000 | -14.3% | 24,600 | +25.5% | 0.26% | -45.0% |
| CCCC | C4 THERAPEUTICS INC | $740,000 | +11.6% | 20,000 | 0.0% | 0.25% | -28.5% | |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $670,000 | – | 200,000 | +100.0% | 0.23% | – |
| MRNA | New | MODERNA INCcall | $655,000 | – | 5,000 | +100.0% | 0.22% | – |
| XFOR | New | X4 PHARMACEUTICALS INC | $646,000 | – | 75,000 | +100.0% | 0.22% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $625,000 | – | 10,000 | +100.0% | 0.21% | – |
| PCVX | VAXCYTE INC | $593,000 | -25.6% | 30,000 | 0.0% | 0.20% | -52.4% | |
| IMTXW | Sell | IMMATICS N.V*w exp 07/01/2020 | $590,000 | -15.6% | 200,000 | -17.6% | 0.20% | -46.1% |
| AXSM | AXSOME THERAPEUTICS INC | $566,000 | -30.6% | 10,000 | 0.0% | 0.19% | -55.6% | |
| BYSI | Sell | BEYONDSPRING INC | $554,000 | -39.5% | 50,000 | -33.3% | 0.19% | -61.2% |
| EPZM | New | EPIZYME INC | $436,000 | – | 50,000 | +100.0% | 0.15% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $418,000 | – | 20,000 | +100.0% | 0.14% | – |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $414,000 | – | 25,000 | +100.0% | 0.14% | – |
| CTMX | New | CYTOMX THERAPEUTICS INC | $387,000 | – | 50,000 | +100.0% | 0.13% | – |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/2020 | $312,000 | -23.7% | 72,466 | 0.0% | 0.11% | -51.2% | |
| WINT | New | WINDTREE THERAPEUTICS INC | $105,000 | – | 42,847 | +100.0% | 0.04% | – |
| VSPRW | Buy | VESPER HEALTHCARE ACQSTN COR*w exp 09/30/2027 | $94,000 | +6.8% | 45,000 | +35.0% | 0.03% | -31.9% |
| ZYNE | ZYNERBA PHARMACEUTICALS INC | $62,000 | +40.9% | 13,285 | 0.0% | 0.02% | -8.7% | |
| VXRT | Exit | VAXART INCput | $0 | – | -25,000 | -100.0% | -0.08% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -3,500 | -100.0% | -0.28% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.30% | – |
| OM | Exit | OUTSET MEDICAL INC | $0 | – | -10,000 | -100.0% | -0.30% | – |
| LYRA | Exit | LYRA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.30% | – |
| SIOX | Exit | SIO GENE THERAPIES INC | $0 | – | -250,000 | -100.0% | -0.37% | – |
| CHAQ | Exit | CHARDAN HEALTHCARE ACQUISITION 2 CORP | $0 | – | -75,000 | -100.0% | -0.42% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.47% | – |
| VSPR | Exit | VESPER HEALTHCARE ACQUISITION CORP | $0 | – | -100,000 | -100.0% | -0.60% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -0.63% | – |
| LGVW | Exit | LONGVIEW ACQUISITION CORP | $0 | – | -75,000 | -100.0% | -0.79% | – |
| MGTX | Exit | MEIRAGTX HOLDINGS PLC | $0 | – | -100,000 | -100.0% | -0.80% | – |
| SLDB | Exit | SOLID BIOSCIENCES INCcall | $0 | – | -250,000 | -100.0% | -1.00% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -904,600 | -100.0% | -1.08% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -25,000 | -100.0% | -1.08% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -1.16% | – |
| ATNX | Exit | ATHENEX INC | $0 | – | -200,000 | -100.0% | -1.17% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -1.25% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -75,000 | -100.0% | -1.84% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -225,000 | -100.0% | -15.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.